Peptide appearance Lyophilized form

Weight Loss

15 000+ verified orders

GLP-2 (Tirzepatide)

In stock

GLP-2 or Tirzepatide (LY3298176, marketed as Mounjaro) is a next-generation dual agonist at the GIP and GLP-1 receptors. It is one of the most advanced incretin-based peptides currently under research. Through its dual receptor activation, it offers a unique profile for optimized metabolic control and weight management. Its effects on glucose metabolism, fat oxidation, and energy balance make it a valuable tool in endocrine and metabolic research.
Available strengths
49,00 €
Buy 2, get 1 free. €100 in paid peptide vials · water excluded
Bundle & save

Arrives 26 – 30 November to Europe

We accept Visa Mastercard Apple Pay (when supported) Google Pay (when supported) Klarna (where available) Shown at checkout

GLP-2 (Tirzepatide)

Price range: 39,90 € through 119,00 €

Dual incretin analogue for GLP-1 and GIP receptor pathway studies.

SKU: ADRIA-TIRZ Categories: ,

Compound information

Specifications

Molecular profile

Sequence
Y-Aib-EGTFTSDYSI-Aib-LDKIAQ-K(AEEA-AEEA-gamma-Glu-C20 diacid)-AFVQWLIAGGPSSGAPPPS-NH2
Molecular mass
4813.45 g/mol
CAS number
2023788-19-2
Molecular formula
C225H348N48O68

Material record

Physical appearance
White to off-white lyophilized powder
Solubility
Soluble in bacteriostatic water and suitable aqueous laboratory solvents.
Product note
Dual GIPR/GLP-1R pathway research compound; supplied strictly for research use only.

Research overview

GLP-2 (Tirzepatide)

What is Tirzepatide?

Tirzepatide is a dual incretin receptor agonist that simultaneously activates the GLP-1 (Glucagon-Like Peptide-1)and GIP (Glucose-Dependent Insulinotropic Polypeptide) receptors.

This dual mechanism makes it a next-generation peptide in metabolic and weight regulation research, combining the glucose-lowering effects of GLP-1 agonists with the metabolic advantages of GIP stimulation.

By activating both signaling pathways, Tirzepatide has shown strong potential in preclinical and clinical studies for improving insulin sensitivity, reducing body fat, and optimizing energy metabolism.

Ideal for metabolic health, insulin regulation, and obesity mechanism research.

Key Research Findings

  • Dual Receptor Activation: Stimulates both GLP-1 and GIP receptors for synergistic metabolic enhancement.
  • Glucose Regulation: Promotes insulin secretion and improves glucose homeostasis.
  • Fat Reduction: Leads to body fat reduction while maintaining lean body mass.
  • Appetite Control: Regulates central mechanisms controlling hunger and satiety.
  • Energy Metabolism: Enhances mitochondrial efficiency and fat oxidation.

Research areas

  • Dual agonism at GIP and GLP-1 receptors, with a synergistic effect
  • Weight loss of up to 22.5% reported in the SURMOUNT trials
  • HbA1c reduction exceeding that of semaglutide in the SURPASS programme
  • Cardiovascular markers and liver-fat measures
  • Exploratory work in sleep apnoea and heart failure

Detailed Mechanism of Action

Tirzepatide is built on the native GIP backbone and engineered to engage the GLP-1 receptor as well. At the GIP receptor it binds with affinity comparable to native GIP; at the GLP-1 receptor it is roughly five-fold weaker than native GLP-1. This imbalance is deliberate, and it is a central reason researchers buy tirzepatide rather than a single-target incretin analog.

Once bound, both receptors couple to Gαs and raise intracellular cyclic AMP in pancreatic beta cells. The downstream effects documented in published models include glucose-dependent insulin secretion, suppression of glucagon release, slowed gastric emptying, and reduced food intake mediated through hypothalamic and hindbrain circuits.

At the GLP-1 receptor, tirzepatide shows biased signaling: it favors cAMP generation over β-arrestin recruitment, which limits receptor internalization and may sustain signaling over time. Willard and colleagues (2020) described this “imbalanced and biased” profile in detail, and it remains a popular topic for groups who buy tirzepatide for receptor pharmacology work.

The C20 fatty diacid moiety, attached through a hydrophilic linker at lysine 20, binds serum albumin and shields the peptide from renal clearance. Combined with the Aib residues at positions 2 and 13 that resist DPP-4 cleavage, this gives tirzepatide the extended half-life and once-weekly profile reported in the literature.

Published Research

Tirzepatide (originally LY3298176) was first characterized by Coskun and colleagues in 2018 in Molecular Metabolism, which documented its receptor affinities, five-day half-life, and early proof-of-concept data. Researchers who buy tirzepatide for in vitro work often use this paper as the reference standard for receptor-binding assays.

In the SURPASS-2 trial, Frías et al. (2021, NEJM) compared tirzepatide 5, 10, and 15 mg against semaglutide 1 mg over 40 weeks in 1,879 participants. HbA1c reductions of 2.01 to 2.30 percentage points and body-weight reductions of 7.6 to 11.2 kg exceeded semaglutide’s 1.86 points and 5.7 kg.

In SURMOUNT-1, Jastreboff et al. (2022, NEJM) reported mean weight reductions of 15.0%, 19.5%, and 20.9% at the 5, 10, and 15 mg doses over 72 weeks, versus 3.1% with placebo, in 2,539 adults with obesity. These datasets are the benchmark that laboratories cite when they buy tirzepatide to design comparative incretin studies.

Because this is a research compound, none of these clinical findings are claims about the product sold here. They explain why demand for the peptide is so high in 2026, and why a verified-purity source matters when you buy tirzepatide for your own protocols.

Why Choose Tirzepatide?

  • Tirzepatide is one of the most advanced incretin-based peptides currently under research.
  • Through its dual receptor activation, it offers a unique profile for optimized metabolic control and weight management.
  • Its effects on glucose metabolism, fat oxidation, and energy balance make it a valuable tool in endocrine and metabolic research.

Order Tirzepatide and explore its potential in advanced metabolic and obesity research.

Published work examines how the two incretin-receptor pathways interact, along with the compound's sequence design, receptor selectivity, binding behaviour, and downstream metabolic signalling in controlled research. Batch-specific identity and measured content remain governed by the signed analytical record for each strength.

All presented information is based on scientific publications which can be found in

For laboratory purposes and personal observation only. Not for human consumption.

Laboratory care

Handling

Peptides in transport

Peptides in lyophilized form are supplied in glass vials by standard shipping methods and do not require refrigeration. Short-term temperature fluctuations during transport will not reduce their quality and efficacy. Even at high summer temperatures, the peptides in lyophilized form are stable for several weeks.

Storage of lyophilized peptides

Lyophilized peptides should be stored in a dry place, protected from light and moisture. The following storage conditions are generally recommended:

  • Room temperature (15–25 °C): Up to 3 months
  • Refrigerated (2–8 °C): Up to 6 months
  • Frozen (-20 °C or below): 3–5 years (recommended for long-term storage)

Allow the vial to reach room temperature after taking it out of the refrigerator or freezer.

Storage of reconstituted peptides

Once reconstituted, peptide solutions are generally less stable than their lyophilized form and should be stored under refrigerated conditions whenever possible.

The following storage conditions are generally recommended:

  • Room temperature (15–25 °C): Avoid prolonged storage
  • Refrigerated (2–8 °C): Typically 4–8 weeks
  • Frozen (-20 °C or below): Up to 3–4 months

To preserve peptide integrity, avoid repeated freeze–thaw cycles, as these may accelerate peptide degradation.

Important: Most manufacturers recommend discarding reconstituted peptides within 4 weeks when stored at 2–8 °C. This recommendation is intentionally conservative and may not reflect the actual chemical stability of every peptide. In our own stability studies, many peptides reconstituted in bacteriostatic water showed no detectable degradation after 12 weeks of refrigerated storage. As peptide stability is highly sequence- and formulation-dependent, this result should not be extrapolated to all peptides without supporting stability data.

Analytical documentation

Tests

Latest published result

Liquilabs s.r.o.Signed Certificate of Analysis · 15mg

99.8%Purity by HPLC

Batch number
6948886
Tested
2026-08-06

Recorded QC panel

AssayPeptide screening
13.41 mg
PurityPeptide screening
99.8%
Identity (FTIR)FTIR spectrum
995
Identity (RT)Retention time
0.997
Bacterial EndotoxinUSP / Eur. Ph. 2.6.14
0.056 EU/mg
Molecular Ion MassMS deconvolution
4813 Da

These are the latest published results for this strength. The batch number is printed on each vial. Your supplied batch is confirmed against the matching published record when your order is allocated.

See all test results

Signed certificate

Source record

References

1.

Coskun T, Sloop KW, Loghin C, et al. · 2018

LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept

Discovery and receptor pharmacology of LY3298176.

Molecular Metabolism · 10.1016/j.molmet.2018.09.009 View source ↗
2.

National Center for Biotechnology Information

PubChem Compound Summary: Tirzepatide

Authoritative identity record for tirzepatide.

PubChem View source ↗
3.

Frías JP, Davies MJ, Rosenstock J, et al. · 2021

Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes

Primary clinical research report for the compound described as tirzepatide.

The New England Journal of Medicine · 10.1056/nejmoa2107519 View source ↗
4.

National Center for Biotechnology Information

PubChem compound record

PubChem View source ↗

Customer reviews

4.7/5185+ reviews
View on Trustpilot ↗Checked 17 Nov 2026

Quality products,fast shipping,great refferal plan,only downside is that products in 4 mounths since my first order got more and more expensive ,but overall verry good experience.

Read full review →

More than 2 weeks for package dispatch. They promised one free peptide next time. Sent me new tracking number but package still wasn't delivered to fedex. Last package (much much cheaper) was delivered in less than week. I will update if they will send my package. ok,package sent.

Read full review →

Extremely satisfied with the product quality and overall experience. The customer service is polite and quick. All recommendations!

Read full review →

Trustworthy site with a huge catalog of products. Been purchasing from them for some time now never got disappointed. I could only recommend them.

Read full review →

Everything ok. With little problem with package, but after contact with Customer Service everything went right. Good quality of products

Read full review →

Excellent. Buying peptides online can be nerve wracking! But Adria are very transparent about all the checks and certifications. My experience with them was excellent. Great products at good prices and efficient P&P

Read full review →